These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19326578)

  • 1. The A-to-Z of omega-3. Why this fatty acid is a must for good health.
    Neithercott T
    Diabetes Forecast; 2009 Feb; 62(2):45-8. PubMed ID: 19326578
    [No Abstract]   [Full Text] [Related]  

  • 2. Fish oil, blood vessels, and depression.
    Krishnan KR
    Biol Psychiatry; 2010 Jul; 68(2):116-7. PubMed ID: 20609837
    [No Abstract]   [Full Text] [Related]  

  • 3. [n-3 and n-6 fatty acids in plasma at birth and at one year and the relationship with the type of feeding].
    Moreno Villares JM
    An Pediatr (Barc); 2009 Feb; 70(2):189-90. PubMed ID: 19217578
    [No Abstract]   [Full Text] [Related]  

  • 4. Mental retardation is associated with plasma omega-3 fatty acid levels and the omega-3/omega-6 ratio in children.
    Neggers YH; Kim EK; Song JM; Chung EJ; Um YS; Park T
    Asia Pac J Clin Nutr; 2009; 18(1):22-8. PubMed ID: 19329391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What you should know about omega-3 fatty acids and prostate cancer.
    Stohs SJ; Goldberg K
    J Diet Suppl; 2014 Dec; 11(4):476-8. PubMed ID: 24689516
    [No Abstract]   [Full Text] [Related]  

  • 6. Omega-3 and prostate cancer: examining the pertinent evidence.
    McCarty MF; DiNicolantonio JJ; Lavie CJ; O'Keefe JH
    Mayo Clin Proc; 2014 Apr; 89(4):444-50. PubMed ID: 24613035
    [No Abstract]   [Full Text] [Related]  

  • 7. Polyunsaturated fatty acid consumption and concentration among South Indian women during pregnancy.
    Dwarkanath P; Muthayya S; Thomas T; Vaz M; Parikh P; Mehra R; Kurpad AV
    Asia Pac J Clin Nutr; 2009; 18(3):389-94. PubMed ID: 19786387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful, harmless or helpful? The n-6 fatty acid debate goes on.
    Calder PC; Deckelbaum RJ
    Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):113-4. PubMed ID: 21311251
    [No Abstract]   [Full Text] [Related]  

  • 9. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Tokudome S; Ando R; Ichikawa Y; Ichikawa H; Imaeda N; Goto C; Tokudome Y; Okuyama H
    J Natl Cancer Inst; 2014 Apr; 106(4):dju020. PubMed ID: 24685933
    [No Abstract]   [Full Text] [Related]  

  • 10. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Cleland LG; Proudman SM; James MJ
    J Natl Cancer Inst; 2014 Apr; 106(4):dju022. PubMed ID: 24685932
    [No Abstract]   [Full Text] [Related]  

  • 11. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    McCarty MF; Dinicolantonio JJ; Lavie CJ; O'Keefe JH
    J Natl Cancer Inst; 2014 Apr; 106(4):dju014. PubMed ID: 24685931
    [No Abstract]   [Full Text] [Related]  

  • 12. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Torfadottir JE; Stampfer MJ; Mucci LA; Giovannucci EL
    J Natl Cancer Inst; 2014 Apr; 106(4):dju018. PubMed ID: 24685929
    [No Abstract]   [Full Text] [Related]  

  • 13. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Harris WS; Davidson MH
    J Natl Cancer Inst; 2014 Apr; 106(4):dju019. PubMed ID: 24685928
    [No Abstract]   [Full Text] [Related]  

  • 14. RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    McCulloch M; Alvarez E; Gendreau R; Haney S; Harrelson J; Luo R
    J Natl Cancer Inst; 2014 Apr; 106(4):dju024. PubMed ID: 24685926
    [No Abstract]   [Full Text] [Related]  

  • 15. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    El-Bayoumy K; Thompson H; Manni A
    J Natl Cancer Inst; 2014 Apr; 106(4):dju017. PubMed ID: 24685921
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Taneja SS
    J Urol; 2014 Mar; 191(3):658. PubMed ID: 24522035
    [No Abstract]   [Full Text] [Related]  

  • 17. Response.
    Brasky TM; Thompson IM; King IB; Kristal AR
    J Natl Cancer Inst; 2014 Apr; 106(4):dju021. PubMed ID: 24685927
    [No Abstract]   [Full Text] [Related]  

  • 18. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.
    De Caterina R; Madonna R; Bertolotto A; Schmidt EB
    Diabetes Care; 2007 Apr; 30(4):1012-26. PubMed ID: 17251279
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential fatty acids.
    Lerman RH
    Altern Ther Health Med; 2006; 12(3):20-9; quiz 30-1. PubMed ID: 16708767
    [No Abstract]   [Full Text] [Related]  

  • 20. Words of wisdom: Re: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Sosnowski R; Zawistowski J
    Eur Urol; 2014 May; 65(5):1012. PubMed ID: 24646497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.